NCT01394887View on ClinicalTrials.gov

Metformin & Inflammation in Pre-diabetic Children

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

July 31, 2003

Study Completion Date

July 31, 2011

Conditions
Glucose IntoleranceInflammationDiabetes
Interventions
DRUG

Metformin

850 mg of metformin twice daily over 12 weeks

DRUG

placebo

850 mg gel capsules with starch (6.8 calories)as placebo

Trial Locations (1)

06720

"Endocrine Outpatient Clinic of the Hospital de Pediatria del CMN Siglo XXI", Mexico City

All Listed Sponsors
lead

Coordinación de Investigación en Salud, Mexico

OTHER_GOV

NCT01394887 - Metformin & Inflammation in Pre-diabetic Children | Biotech Hunter | Biotech Hunter